Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex ...
If you're chronically achy, these moves and meds can provide reliefGentle exercise can help reduce back pain and prevent ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.
All three cannabinoids reduced the electrical activity linked to Nav1.8, but CBG had the strongest effect. This suggests that CBG could be the most promising candidate for developing new pain ...
People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...
The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.
On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...
Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...